Nicolas Mourier
Amministratore Delegato presso Approach SAS
Profilo
Nicolas Mourier is currently the Chief Executive Officer at Approach SAS since 2010.
Prior to this, he worked as the Director-Product Development at Peptimmune, Inc. from 2008 to 2011.
He also held positions as Principal at Johnson Matthey, Inc. and Wolfe Laboratories, Inc. Dr. Mourier holds a doctorate degree from Emory University and Université d'Aix-Marseille.
Posizioni attive di Nicolas Mourier
Società | Posizione | Inizio |
---|---|---|
Approach SAS
Approach SAS Specialty StoresRetail Trade Approach SASU markets outdoor and sports equipments. The company was founded on December 4, 2006 and is headquartered in Valence, France. | Amministratore Delegato | 18/09/2010 |
Precedenti posizioni note di Nicolas Mourier
Società | Posizione | Fine |
---|---|---|
Peptimmune, Inc.
Peptimmune, Inc. BiotechnologyHealth Technology Peptimmune was founded in 2002 with technology from the laboratories of Dr. Jack Strominger, Higgins Professor of Biochemistry at Harvard University; and Dr. Hidde Ploegh, from the Whitehead Institute for Biomedical Research. Peptimmune has therapeutics in clinical development for the treatment of multiple sclerosis. Peptimmune's flagship program in multiple sclerosis features PI-2301, which has the opportunity to replace Copaxone® (Teva Pharmaceuticals), the world's leading first-line therapy for the treatment of MS. Peptimmune has broad expertise in MHC Class II molecules and their role in antigen presentation and modulation of immune responses. The Company exploits its proprietary DEEP Technology (Directed Expansion of Epitope Permutation) to design peptides and peptide mixtures for development as therapeutics, diagnostic kits, and as reagents for antibody generation. The Company is building a unique suite of expertise in the manufacture and control of peptide copolymer-based drug products. | Corporate Officer/Principal | 27/10/2011 |
Wolfe Laboratories, Inc.
Wolfe Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Wolfe Laboratories, Inc. operates as a contract research organization which provides integrated drug development solutions to the biopharmaceutical industry. It offers small molecule drug development, biologics development, and antibody-drug conjugates development services. The company was founded by Janet Wolfe in 1999 and is headquartered in Woburn, MA. | Corporate Officer/Principal | - |
Johnson Matthey, Inc.
Johnson Matthey, Inc. Wholesale DistributorsDistribution Services Johnson Matthey, Inc. manufactures pharmaceutical ingredients. It provides research and development services for the pharmaceutical industry. The firm manufactures and supplies photovoltaic cell materials, photovoltaic dyes, and photovoltaic cells. The company is headquartered in Wayne, PA. | Corporate Officer/Principal | - |
Formazione di Nicolas Mourier
Emory University | Doctorate Degree |
Université d'Aix-Marseille | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 4 |
---|---|
Peptimmune, Inc.
Peptimmune, Inc. BiotechnologyHealth Technology Peptimmune was founded in 2002 with technology from the laboratories of Dr. Jack Strominger, Higgins Professor of Biochemistry at Harvard University; and Dr. Hidde Ploegh, from the Whitehead Institute for Biomedical Research. Peptimmune has therapeutics in clinical development for the treatment of multiple sclerosis. Peptimmune's flagship program in multiple sclerosis features PI-2301, which has the opportunity to replace Copaxone® (Teva Pharmaceuticals), the world's leading first-line therapy for the treatment of MS. Peptimmune has broad expertise in MHC Class II molecules and their role in antigen presentation and modulation of immune responses. The Company exploits its proprietary DEEP Technology (Directed Expansion of Epitope Permutation) to design peptides and peptide mixtures for development as therapeutics, diagnostic kits, and as reagents for antibody generation. The Company is building a unique suite of expertise in the manufacture and control of peptide copolymer-based drug products. | Health Technology |
Johnson Matthey, Inc.
Johnson Matthey, Inc. Wholesale DistributorsDistribution Services Johnson Matthey, Inc. manufactures pharmaceutical ingredients. It provides research and development services for the pharmaceutical industry. The firm manufactures and supplies photovoltaic cell materials, photovoltaic dyes, and photovoltaic cells. The company is headquartered in Wayne, PA. | Distribution Services |
Wolfe Laboratories, Inc.
Wolfe Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Wolfe Laboratories, Inc. operates as a contract research organization which provides integrated drug development solutions to the biopharmaceutical industry. It offers small molecule drug development, biologics development, and antibody-drug conjugates development services. The company was founded by Janet Wolfe in 1999 and is headquartered in Woburn, MA. | Health Technology |
Approach SAS
Approach SAS Specialty StoresRetail Trade Approach SASU markets outdoor and sports equipments. The company was founded on December 4, 2006 and is headquartered in Valence, France. | Retail Trade |
- Borsa valori
- Insiders
- Nicolas Mourier